HIV-1 viral load and resistance in genital secretions in patients taking protease-inhibitor-based second-line therapy in Africa.,Antiviral Therapy

当前位置： X-MOL 学术 › Antivir. Ther. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

HIV-1 viral load and resistance in genital secretions in patients taking protease-inhibitor-based second-line therapy in Africa.
Antiviral Therapy ( IF 1.3 ) Pub Date : 2017-10-13 , DOI: 10.3851/imp3200
Anne Hoppe _{1,

2} , Marina Giuliano ₃ , Abbas Lugemwa ₄ , Jennifer A Thompson ₂ , Marco Floridia ₃ , Ann S Walker ₂ , Ismail Senoga ₅ , Mary C Abwola ₆ , Maria F Pirillo ₃ , Cissy M Kityo ₇ , Alejandro Arenas-Pinto ₂ , Nicholas I Paton _{2,

8} ,

Affiliation

HIV is transmitted primarily through sexual intercourse, and the objective of this study was therefore to assess whether there is occult viral replication and resistance in genital secretions in patients on protease inhibitor (PI)-based second-line therapy.

中文翻译：